- Home
- OCC vs VNRX Comparison
OCC vs VNRX Comparison
Compare OCC & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- VNRX
- Stock Information
- Founded
- OCC 1983
- VNRX N/A
- Country
- OCC United States
- VNRX United States
- Employees
- OCC N/A
- VNRX N/A
- Industry
- OCC Telecommunications Equipment
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OCC Industrials
- VNRX Health Care
- Exchange
- OCC Nasdaq
- VNRX Nasdaq
- Market Cap
- OCC 42.9M
- VNRX 45.2M
- IPO Year
- OCC 1996
- VNRX N/A
- Fundamental
- Price
- OCC $2.85
- VNRX $0.49
- Analyst Decision
- OCC
- VNRX Strong Buy
- Analyst Count
- OCC 0
- VNRX 5
- Target Price
- OCC N/A
- VNRX $3.75
- AVG Volume (30 Days)
- OCC 21.4K
- VNRX 310.7K
- Earning Date
- OCC 06-09-2025
- VNRX 05-12-2025
- Dividend Yield
- OCC N/A
- VNRX N/A
- EPS Growth
- OCC N/A
- VNRX N/A
- EPS
- OCC N/A
- VNRX N/A
- Revenue
- OCC $67,561,951.00
- VNRX $1,233,511.00
- Revenue This Year
- OCC N/A
- VNRX $812.84
- Revenue Next Year
- OCC N/A
- VNRX $162.93
- P/E Ratio
- OCC N/A
- VNRX N/A
- Revenue Growth
- OCC N/A
- VNRX 59.10
- 52 Week Low
- OCC $2.02
- VNRX $0.42
- 52 Week High
- OCC $7.00
- VNRX $1.02
- Technical
- Relative Strength Index (RSI)
- OCC 41.97
- VNRX 42.51
- Support Level
- OCC $2.80
- VNRX $0.45
- Resistance Level
- OCC $3.07
- VNRX $0.54
- Average True Range (ATR)
- OCC 0.26
- VNRX 0.07
- MACD
- OCC 0.05
- VNRX -0.00
- Stochastic Oscillator
- OCC 66.18
- VNRX 33.33
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.